Brief Information of the Cell Line and Protein
Cell Line ID: CL000257 , MDA-kb2
Synonyms
MDA-Kb2
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_6421
Protein ID: PT01478 , Heat shock protein HSP 90-beta
Gene Name HSP90AB1
Organism Homo sapiens, Human
Protein Classification Other cytosolic protein
Uniprot ID P08238
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000257  Protein ID: PT01478
 
Compound ID Compound Name Compound Formula
CP0042181
CHEBI:5292
   Show/Hide
C29H40N2O9
 1
1
IC50 < 10 nM
   TI
   LI
   LO
   TS
CP0844359
(S)-4-((S)-2-((3S,4S,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S)-28-((1H-imidazol-5-yl)methyl)-13-((1H-indol-3-yl)methyl)-4-((2S,5S,8S,11S,19S)-5-((1H-indol-3-yl)methyl)-11-carbamoyl-2,8-diisobutyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentaazacycloicosan-19-ylcarbamoyl)-37-amino-22-(2-amino-2-oxoethyl)-16-sec-butyl-10,19-bis(3-guanidinopropyl)-31-((R)-1-hydroxyethyl)-3,25-dimethyl-7-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,37-undecaoxo-5,8,11,14,17,20,23,26,29,32-decaazaheptatriacontan-34-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C106H162N32O25S
 1
1
IC50 = 730 nM
   TI
   LI
   LO
   TS
CP0912369
(S)-4-((S)-2-((5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S)-35-((1H-imidazol-5-yl)methyl)-1,44-diamino-29-(2-amino-2-oxoethyl)-11-(4-aminobutyl)-14,23-di-sec-butyl-17,26-bis(3-guanidinopropyl)-20-(4-hydroxybenzyl)-38-((R)-1-hydroxyethyl)-5,8-diisobutyl-32-methyl-1,4,7,10,13,16,19,22,25,28,31,34,37,40,44-pentadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazatetratetracontan-41-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C86H142N28O23
 1
1
IC50 = 10400 nM
   TI
   LI
   LO
   TS
CP0072117
Coumermycin A1
   Show/Hide
C55H59N5O20
 1
1
IC50 = 15300 nM
   TI
   LI
   LO
   TS
CP0958186
(S)-4-((S)-2-((5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S)-41-((1H-imidazol-5-yl)methyl)-1,50-diamino-35-(2-amino-2-oxoethyl)-14-(4-aminobutyl)-17,29-di-sec-butyl-23,32-bis(3-guanidinopropyl)-26-(4-hydroxybenzyl)-44-((R)-1-hydroxyethyl)-5,11-diisobutyl-8,20,38-trimethyl-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,50-heptadecaoxo-8,20-di(pent-4-enyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaazapentacontan-47-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C102H168N30O25
 1
1
IC50 = 15800 nM
   TI
   LI
   LO
   TS
CP0912370
(S)-4-((S)-2-((5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S)-41-((1H-imidazol-5-yl)methyl)-8-((1H-indol-3-yl)methyl)-1,50-diamino-35-(2-amino-2-oxoethyl)-14-(4-aminobutyl)-17,29-di-sec-butyl-23,32-bis(3-guanidinopropyl)-26-(4-hydroxybenzyl)-44-((R)-1-hydroxyethyl)-5,11-diisobutyl-38-methyl-20-(2-(methylthio)ethyl)-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,50-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaazapentacontan-47-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C102H161N31O25S
 1
1
IC50 = 16800 nM
   TI
   LI
   LO
   TS
CP0921259
(S)-4-((S)-2-((5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S)-41-((1H-imidazol-5-yl)methyl)-1,50-diamino-35-(2-amino-2-oxoethyl)-14-(4-aminobutyl)-17,29-di-sec-butyl-23,32-bis(3-guanidinopropyl)-26-(4-hydroxybenzyl)-44-((R)-1-hydroxyethyl)-5,8,11-triisobutyl-38-methyl-20-(2-(methylthio)ethyl)-1,4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,50-heptadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaazapentacontan-47-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C97H162N30O25S
 1
1
IC50 = 18600 nM
   TI
   LI
   LO
   TS
CP0811657
(S)-4-((S)-2-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-24-((1H-imidazol-5-yl)methyl)-1,33-diamino-18-(2-amino-2-oxoethyl)-6-((3S,6S,9S,12S,21S,E)-21-((S)-1-(2-amino-2-oxoethylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)-6-(4-aminobutyl)-9-sec-butyl-3-isobutyl-12,21-dimethyl-2,5,8,11-tetraoxo-1,4,7,10-tetraazacyclohenicos-16-en-12-ylcarbamoyl)-12-sec-butyl-15-(3-guanidinopropyl)-9-(4-hydroxybenzyl)-27-((R)-1-hydroxyethyl)-1-imino-21-methyl-8,11,14,17,20,23,26,29,33-nonaoxo-2,7,10,13,16,19,22,25,28-nonaazatritriacontan-30-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C100H164N30O25
 1
1
IC50 = 18800 nM
   TI
   LI
   LO
   TS
CP0930841
(S)-4-((S)-2-((3S,4S,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S)-28-((1H-imidazol-5-yl)methyl)-4-((2S,5S,8S,11S,19S)-5-((1H-indol-3-yl)methyl)-11-carbamoyl-2,8-diisobutyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentaazacycloicosan-19-ylcarbamoyl)-37-amino-22-(2-amino-2-oxoethyl)-16-sec-butyl-10,19-bis(3-guanidinopropyl)-13-(4-hydroxybenzyl)-31-((R)-1-hydroxyethyl)-3,25-dimethyl-7-(2-(methylthio)ethyl)-6,9,12,15,18,21,24,27,30,33,37-undecaoxo-5,8,11,14,17,20,23,26,29,32-decaazaheptatriacontan-34-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C104H161N31O26S
 1
1
IC50 > 27000 nM
   TI
   LI
   LO
   TS
CP0949728
(S)-4-((S)-2-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-24-((1H-imidazol-5-yl)methyl)-1,33-diamino-18-(2-amino-2-oxoethyl)-6-((2S,5S,8S,11S,19S)-11-((S)-1-(2-amino-2-oxoethylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)-5-(4-aminobutyl)-2-sec-butyl-8-isobutyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentaazacycloicosan-19-ylcarbamoyl)-12-sec-butyl-15-(3-guanidinopropyl)-9-(4-hydroxybenzyl)-27-((R)-1-hydroxyethyl)-1-imino-21-methyl-8,11,14,17,20,23,26,29,33-nonaoxo-2,7,10,13,16,19,22,25,28-nonaazatritriacontan-30-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
   Show/Hide
C96H157N31O26
 1
1
IC50 > 67000 nM
   TI
   LI
   LO
   TS